Literature DB >> 23095304

Prospective memory and antiretroviral medication non-adherence in HIV: an analysis of ongoing task delay length using the memory for intentions screening test.

Amelia J Poquette1, David J Moore, Ben Gouaux, Erin E Morgan, Igor Grant, Steven Paul Woods.   

Abstract

Using multi-process framework by McDaniel and Einstein (2000), the current study examined whether the length of prospective memory (PM) delay intervals as measured by the 2- and 15-min subscales of the Memory for Intentions Screening Test (MIST) have differential predictive value for antiretroviral (ARV) adherence. Participants included 74 HIV-infected individuals whose ARV adherence was tracked with an electronic monitoring system. Participants were classified as "adherent" (n = 49) or "non-adherent" (n = 25) based on recorded pill bottle openings of ≥90% of prescribed doses over 30 days. An adherence group by MIST delay interval interaction was observed, such that non-adherent participants had worse performance on the 15-min, but not 2-min delay PM MIST subscales. The observed MIST 15-min delay effects were significantly more pronounced on time- versus event-cued PM trials. Long-delay time-based PM was predictive of non-adherence independent of demographics, mood state, self-reported adherence, and general cognitive functioning. Findings from this clinical study indicate that ARV non-adherence may be particularly associated with deficits in strategic cue monitoring over longer PM delays, which may inform interventions to improve adherence among persons living with HIV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23095304      PMCID: PMC3693472          DOI: 10.1017/S1355617712001051

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  19 in total

1.  Norms for letter and category fluency: demographic corrections for age, education, and ethnicity.

Authors:  J A Gladsjo; C C Schuman; J D Evans; G M Peavy; S W Miller; R K Heaton
Journal:  Assessment       Date:  1999-06

2.  HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence.

Authors:  David J Moore; Carolina Posada; Mili Parikh; Miguel Arce; Florin Vaida; Patricia K Riggs; Ben Gouaux; Ronald J Ellis; Scott L Letendre; Igor Grant; J Hampton Atkinson
Journal:  AIDS Behav       Date:  2012-11

3.  Longer ongoing task delay intervals exacerbate prospective memory deficits in HIV-associated neurocognitive disorders (HAND).

Authors:  Erin E Morgan; Erica Weber; Alexandra S Rooney; Igor Grant; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2012-02-02       Impact factor: 2.475

4.  Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Raul Gonzalez; Emily Conover; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

5.  Action (verb) fluency: test-retest reliability, normative standards, and construct validity.

Authors:  Steven Paul Woods; J Cobb Scott; Danielle A Sires; Igor Grant; Robert K Heaton; Alexander I Tröster
Journal:  J Int Neuropsychol Soc       Date:  2005-07       Impact factor: 2.892

6.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

7.  A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment.

Authors:  Adriana S A Andrade; Henraya F McGruder; Albert W Wu; Shivaun A Celano; Richard L Skolasky; Ola A Selnes; I-Chan Huang; Justin C McArthur
Journal:  Clin Infect Dis       Date:  2005-08-05       Impact factor: 9.079

8.  The 50 and 100-item short forms of the Paced Auditory Serial Addition Task (PASAT): demographically corrected norms and comparisons with the full PASAT in normal and clinical samples.

Authors:  Michael C Diehr; Mariana Cherner; Tanya J Wolfson; S Walden Miller; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2003-06       Impact factor: 2.475

9.  Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

Authors:  C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

Review 10.  Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature.

Authors:  Adriana Ammassari; Maria Paola Trotta; Rita Murri; Francesco Castelli; Pasquale Narciso; Pasquale Noto; Jacopo Vecchiet; Antonella D'Arminio Monforte; Albert W Wu; Andrea Antinori
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

View more
  15 in total

1.  Pill Burden Influences the Association Between Time-Based Prospective Memory and Antiretroviral Therapy Adherence in Younger But Not Older HIV-Infected Adults.

Authors:  David P Sheppard; Erica Weber; Kaitlin B Casaletto; Gunes Avci; Steven Paul Woods
Journal:  J Assoc Nurses AIDS Care       Date:  2016-04-06       Impact factor: 1.354

2.  A systematic review of prospective memory in HIV disease: from the laboratory to daily life.

Authors:  Gunes Avci; David P Sheppard; Savanna M Tierney; Victoria M Kordovski; Kelli L Sullivan; Steven Paul Woods
Journal:  Clin Neuropsychol       Date:  2017-09-27       Impact factor: 3.535

3.  Pain is associated with prospective memory dysfunction in multiple sclerosis.

Authors:  Ashley K Miller; Michael R Basso; Philip J Candilis; Dennis R Combs; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2014-10-23       Impact factor: 2.475

4.  Retrieval cue and delay interval influence the relationship between prospective memory and activities of daily living in older adults.

Authors:  Savanna M Tierney; Romola S Bucks; Michael Weinborn; Erica Hodgson; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2016-02-23       Impact factor: 2.475

5.  Event-based prospective memory is independently associated with self-report of medication management in older adults.

Authors:  Steven Paul Woods; Michael Weinborn; Brenton R Maxwell; Alice Gummery; Kevin Mo; Amanda R J Ng; Romola S Bucks
Journal:  Aging Ment Health       Date:  2014-01-13       Impact factor: 3.658

6.  Predictors of psychotropic medication adherence among HIV+ individuals living with bipolar disorder.

Authors:  Kaitlin B Casaletto; Sara Kwan; Jessica L Montoya; Lisa C Obermeit; Ben Gouaux; Amelia Poquette; Robert K Heaton; J Hampton Atkinson; David J Moore
Journal:  Int J Psychiatry Med       Date:  2016       Impact factor: 1.210

7.  Prospective memory in HIV-associated neurocognitive disorders (HAND): the neuropsychological dynamics of time monitoring.

Authors:  Katie L Doyle; Shayne Loft; Erin E Morgan; Erica Weber; Clint Cushman; Elaine Johnston; Igor Grant; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2013-03-07       Impact factor: 2.475

8.  Development and reliability of the Prospective Memory Assessment for Children & Youth (PROMACY): A preliminary study in a nonclinical sample.

Authors:  Patricia A Garvie; Sharon L Nichols; Paige L Williams; Lynnette L Harris; Betsy Kammerer; Miriam C Chernoff; Veronica Figueroa; Steven Paul Woods
Journal:  Appl Neuropsychol Child       Date:  2018-10-08       Impact factor: 1.493

9.  The effects of HIV disease and older age on laboratory-based, naturalistic, and self-perceived symptoms of prospective memory: does retrieval cue type and delay interval matter?

Authors:  G Avci; S Loft; D P Sheppard; S P Woods
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2016-03-22

10.  A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals.

Authors:  Thomas D Marcotte; Reena Deutsch; Benedict Daniel Michael; Donald Franklin; Debra Rosario Cookson; Ajay R Bharti; Igor Grant; Scott L Letendre
Journal:  J Neuroimmune Pharmacol       Date:  2013-10-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.